This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Abivax, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 39 
1 out of 132 
1 out of 162 
Years Active: 2026
Title: Elisa Azzali - Innovator in RNA Virus Treatment
Introduction
Elisa Azzali is a notable inventor based in Verona, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the treatment of RNA virus infections. Although she currently holds no granted patents, her work is recognized for its potential impact on medical science.
Latest Patent Applications
Elisa Azzali's latest patent application is titled "Aryl-N-Aryl Derivatives for Treating a RNA Virus Infection." This application describes a compound of formula (I) that includes various functional groups, such as a —CO—NR— group and a —NR′—CO— group, among others. The application outlines the potential of these compounds in treating RNA virus infections, showcasing her innovative approach to addressing significant health challenges.
Conclusion
Elisa Azzali's work exemplifies the spirit of innovation in the pharmaceutical industry. Her research efforts, particularly in developing treatments for RNA virus infections, highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile